SCHEMBL5199877

SCHEMBL5199877

CCCNC(=O)c1cnco1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.53
ACACB O00763 2/20 0.41
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 1/20 0.41
HRH3 Q9Y5N1 1/20 0.41
TP53 P04637 2/20 0.40
HPGD P15428 2/20 0.40
NPC1 O15118 1/20 0.40
LMNA P02545 1/20 0.40
GAA P10253 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
NAMPT P43490 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
DGAT2 Q96PD7 1/20 0.38
MAOB P27338 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
F2R P25116 1/20 0.38
CHRNB2 P17787 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18896237 0.87 NAAA (0.54) ALDH1A1KDM4EHPGDLMNASMN1; SMN2
SCHEMBL17725298 0.86 ACACB (0.43) POLBACACBHRH3HPGDNPC1
SCHEMBL8551555 0.81 CYP1A2 (0.47) POLBACACBALDH1A1KDM4EHRH3
SCHEMBL23799182 0.80 HRH3 (0.39) ACACBALDH1A1HRH3LMNASMN1; SMN2
SCHEMBL7876851 0.79 ACACB (0.40) ACACBALDH1A1HRH3HPGDNPC1
SCHEMBL15625519 0.76 MCL1 (0.45) POLBACACBHRH3NAMPTDGAT2
SCHEMBL16027956 0.76
SCHEMBL11777365 0.75 SMN1; SMN2 (0.50) POLBALDH1A1TP53HPGDNPC1
SCHEMBL23052114 0.75 ACACB (0.49) ACACBALDH1A1SMN1; SMN2F2R
SCHEMBL24567585 0.74 ACACB (0.54) POLBACACBALDH1A1HRH3HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1866293-A1 COMPOUNDS COMPRISING AN OXAZOLE OR THIAZOLE MOIETY, PROCESSES FOR MAKING THEM, AND THEIR USES UCB Pharma, S.A. (BE) 2007-12-19 EP claimed
WO-2006103045-A1 COMPOUNDS COMPRISING AN OXAZOLE OR THIAZOLE MOIETY, PROCESSES FOR MAKING THEM, AND THEIR USES UCB PHARMA S.A. (BE) 2006-10-05 WO claimed
US-20210277061-A1 YEATS INHIBITORS AND METHODS OF USE THEREOF THE UNIVERSITY OF HONG KONG (HK) 2021-09-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210277061-A1 YEATS INHIBITORS AND METHODS OF USE THEREOF YEATS2, YEATS4, MLLT1 POLB 1892/4885ACACB 2558/4885ALDH1A1 4258/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.